PET/CT is performed using different radiopharmaceuticals, depending on the organ under study:
PET/CT with glucose (18F-FDG) – for lung cancer, tumors of unknown localization, lymphomas, breast cancer, colorectal cancer, malignant melanoma of the skin, gynecological oncological diseases (ovarian cancer, cervical cancer), esophageal cancer, testicular cancer.
PAT/CT with methionine – for diseases of the brain.
PET / CT with choline (11C) – for diseases of the prostate gland, parathyroid adenoma.
What problem does PET/CT solve?
Diagnosis of neoplasms at the earliest stages.
Assessment of the prevalence of […]Read More